Clinical update: rotavirus gastroenteritis and its prevention

Lancet

Volumn 370, Issue 9584, 2007, Pages 302-304

  Grimwood, Keith ^a   Buttery, Jim P ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; DEVELOPING COUNTRY; DIARRHEA; DRUG SAFETY; GASTROENTERITIS; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL CARE; HUMAN; INTUSSUSCEPTION; PRIORITY JOURNAL; ROTAVIRUS; SOCIETY; UNITED STATES; VIRUS INFECTION;

EID: 34447626622     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61142-8     Document Type: Note

References (20)

1. Soriano-Gabarro M., Mrukowicz J., Vesikari T., and Verstraeten T. Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J 25 suppl (2006) S7-S11
2. Van Damme P., Giaquinto C., Huet F., Gothefors L., Maxwell M., and Van der Wielen M. Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: The REVEAL Study. J Infect Dis 195 suppl 1 (2007) S4-S16
3. Chandran A., Heinzen R., Santosham M., and Siberry G. Nosocomial rotavirus infections: a systematic review. J Pediatr 149 (2006) 441-447
4. Parashar U., Alexander J., and Glass R. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunisation Practices (ACIP). MMWR Morb Mortal Wkly Rep 55 (2006) 1-13
5. Franco M., Angel J., and Greenberg H. Immunity and correlates of protection for rotavirus vaccines. Vaccine 24 (2006) 2718-2731
6. Santos N., and Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 15 (2005) 29-56
7. Velazquez F., Matson D., Calva J., et al. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med 335 (1996) 1022-1028
8. Glass R., Parashar U., Bresee J., et al. Rotavirus vaccines: current prospects and future challenges. Lancet 368 (2006) 323-332
9. Bines J. Intussusception and rotavirus vaccines. Vaccine 24 (2006) 3772-3776
10. Ruiz-Palacios G., Perez-Schael I., Velazquez F., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354 (2006) 11-22
11. Vesikari T., Matson D., Dennehy P., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354 (2006) 23-33
12. Blutt S., and Conner M. Rotaviruses: to the gut and beyond!. Curr Opin Gastroenterol 23 (2007) 39-43
13. Vesikari T, Karvonen A, Prymula R, et al. Human rotavirus vaccine RotarixTM (RIX4414) is highly efficacious in Europe. Annual Meeting of the European Society for Pediatric Infectious Diseases. Basel, Switzerland; May 3-5, 2006. Abstr 75.
14. Cunliffe N., Gondwe J., Kirkwood C., et al. Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children. Lancet 358 (2001) 550-555
15. Tai J., Curns A., Parashar U., Bresee J., and Glass R. Rotavirus vaccination and intussusception: can we decrease temporally associated background cases of intussusception by restricting the vaccination schedule?. Pediatrics 118 (2006) e258-e264
16. US Centers for Disease Control and Prevention (CDC). Postmarketing monitoring of intussusception after RotaTeq vaccination-United States, February 1, 2006-February 15, 2007. MMWR Morb Mortal Wkly Rep 56 (2007) 218-222
17. Vesikari T., Karvonen A., Majuri J., et al. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children. J Infect Dis 194 (2006) 370-376
18. Banerjee I., Primrose Gladstone B., Le Fevre A., et al. Neonatal infection with G10P[11] rotavirus did not confer protection against subsequent rotavirus infection in a community cohort in Vellore, South India. J Infect Dis 195 (2007) 625-632
19. Fischer T., Viboud C., Parashar U., et al. Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993-2003. J Infect Dis 195 (2007) 1117-1125
20. Melliez H., Boelle P., Baron S., Mouton Y., and Yazdanpanah Y. Effectiveness of childhood vaccination against rotavirus in sub-Saharan Africa: the case of Nigeria. Vaccine 25 (2007) 298-305